|
Market Closed -
Nasdaq
16:00:00 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 10.68 USD | -2.47% |
|
0.00% | -41.45% |
| 08-05 | ADMA Biologics, Inc., Q2 2026 Earnings Call, Aug 05, 2026 | |
| 08-05 | Tranche Update on ADMA Biologics, Inc.'s Equity Buyback Plan announced on May 7, 2025. | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.47% | 0.00% | +10.10% | +27.60% | -41.45% | -29.97% | +246.75% | +734.38% | +70.88% | 2.39B | |
| -2.54% | +1.31% | +10.64% | +7.39% | +18.50% | +55.10% | +120.84% | +422.45% | +1,527.42% | 1,135B | |
| -1.42% | +3.23% | -1.99% | +1.75% | +27.48% | +37.07% | +74.26% | +61.13% | +132.55% | 636B | |
| +0.16% | +0.08% | +7.76% | +11.18% | +25.01% | +25.14% | +97.36% | +161.72% | +368.42% | 505B | |
| -0.31% | +3.09% | +7.63% | +11.85% | +19.10% | +43.92% | +64.55% | +9.87% | +68.27% | 378B | |
| -1.34% | -0.47% | -1.90% | +11.34% | +38.01% | +66.63% | +40.56% | +79.01% | +137.37% | 358B | |
| -0.68% | +2.65% | +8.84% | +0.27% | +16.79% | +22.46% | +51.48% | +65.08% | +70.89% | 295B | |
| -1.20% | +3.04% | +3.17% | +1.07% | -7.01% | +2.62% | +26.97% | +42.55% | +158.97% | 266B | |
| -1.79% | +1.57% | +8.17% | +18.24% | +34.20% | +49.97% | +60.87% | +109.93% | +177.12% | 237B | |
| -0.73% | -0.10% | +3.09% | +19.24% | +27.13% | +29.24% | +101.19% | +132.06% | +110.04% | 193B | |
| -1.74% | +0.21% | +3.13% | -18.78% | -20.02% | -24.15% | -61.87% | -23.19% | +83.46% | 172B | |
| -1.28% | +1.52% | +6.56% | +20.07% | +20.60% | +21.73% | -2.63% | -30.42% | -6.68% | 171B | |
| -2.10% | +4.84% | +1.47% | +10.75% | +15.57% | +23.97% | +42.50% | +185.49% | +548.75% | 133B | |
| -2.41% | +2.90% | +0.54% | -0.05% | +13.98% | +40.27% | +9.79% | +6.74% | +22.91% | 126B | |
| -1.14% | -0.41% | +13.66% | +21.38% | +22.00% | +26.21% | +122.39% | +378.63% | +521.48% | 117B | |
| -1.04% | +1.69% | +0.42% | -0.60% | +3.81% | +15.03% | +29.51% | +6.64% | -8.64% | 102B | |
| -1.11% | +3.03% | +1.38% | -2.93% | -10.40% | -14.42% | -24.61% | -12.91% | +7.11% | 99.44B | |
| -1.72% | +1.81% | +0.40% | +23.49% | +4.29% | +39.84% | +1.19% | +40.65% | +121.45% | 80.39B | |
| -1.25% | -8.22% | +9.88% | +250.93% | +578.54% | +662.29% | +154.45% | -38.72% | - | 79.89B | |
| -2.08% | -0.69% | +7.78% | +2.91% | +16.88% | +24.34% | -1.07% | -29.20% | +45.10% | 69.77B | |
| Average | -1.00% | +1.42% | +5.04% | +20.85% | +40.15% | +55.86% | +57.72% | +115.09% | +218.78% | 257.82B | |
| Weighted average by Cap. | -0.45% | +2.34% | +5.43% | +11.26% | +27.51% | +45.16% | +68.35% | +150.10% | +466.55% |
- Stock Market
- Stocks
- ADMA Stock
- Sector ADMA Biologics, Inc.
Select your edition
All financial news and data tailored to specific country editions
